Literature DB >> 23129089

Low total haemoglobin mass, blood volume and aerobic capacity in men with type 1 diabetes.

Anne S Koponen1, Juha E Peltonen, Marja K Päivinen, Jyrki M Aho, Harriet J Hägglund, Arja L Uusitalo, Harri J Lindholm, Heikki O Tikkanen.   

Abstract

Blood O₂ carrying capacity affects aerobic capacity (VO₂max). Patients with type 1 diabetes have a risk for anaemia along with renal impairment, and they often have low VO₂max. We investigated whether total haemoglobin mass (tHb-mass) and blood volume (BV) differ in men with type 1 diabetes (T1D, n = 12) presently without complications and in healthy men (CON, n = 23) (age-, anthropometry-, physical activity-matched), to seek an explanation for low VO₂max. We determined tHb-mass, BV, haemoglobin concentration ([Hb]), and VO₂max in T1D and CON. With similar (mean ± SD) [Hb] (144 vs. 145 g l(-1)), T1D had lower tHb-mass (10.1 ± 1.4 vs. 11.0 ± 1.1 g kg(-1), P < 0.05), BV (76.8 ± 9.5 vs. 83.5 ± 8.3 ml kg(-1), P < 0.05) and VO₂max (35.4 ± 4.8 vs. 44.9 ± 7.5 ml kg(-1) min(-1), P < 0.001) than CON. VO₂max correlated with tHb-mass and BV both in T1D (r = 0.71, P < 0.01 and 0.67, P < 0.05, respectively) and CON (r = 0.54, P < 0.01 and 0.66, P < 0.001, respectively), but not with [Hb]. Linear regression slopes were shallower in T1D than CON both between VO₂max and tHb-mass (2.4 and 3.6 ml kg(-1) min(-1) vs. g kg(-1), respectively) and VO₂max and BV (0.3 and 0.6 ml kg(-1) min(-1) vs. g kg(-1), respectively), indicating that T1D were unable to reach similar VO₂max than CON at a given tHb-mass and BV. In conclusion, low tHb-mass and BV partly explained low VO₂max in T1D and may provide early and more sensitive markers of blood O₂ carrying capacity than [Hb] alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23129089     DOI: 10.1007/s00421-012-2532-4

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  40 in total

Review 1.  The effect of endurance training on parameters of aerobic fitness.

Authors:  A M Jones; H Carter
Journal:  Sports Med       Date:  2000-06       Impact factor: 11.136

2.  Impact of alterations in total hemoglobin mass on VO 2max.

Authors:  Walter Schmidt; Nicole Prommer
Journal:  Exerc Sport Sci Rev       Date:  2010-04       Impact factor: 6.230

3.  Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus.

Authors:  H Mori; M Okubo; M Okamura; K Yamane; S Kado; G Egusa; T Hiramoto; H Hara; M Yamakido
Journal:  Intern Med       Date:  1992-02       Impact factor: 1.271

4.  Oxygen transport impairment in diabetes.

Authors:  J Ditzel
Journal:  Diabetes       Date:  1976       Impact factor: 9.461

Review 5.  Why is erythropoietin made in the kidney? The kidney functions as a critmeter.

Authors:  S Donnelly
Journal:  Am J Kidney Dis       Date:  2001-08       Impact factor: 8.860

6.  Simplified calculation of body-surface area.

Authors:  R D Mosteller
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

7.  Breath-by-breath measurement of true alveolar gas exchange.

Authors:  W L Beaver; N Lamarra; K Wasserman
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-12

Review 8.  Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro)renin receptor: promising young players from the old renin-angiotensin-aldosterone system.

Authors:  Pitchai Balakumar; Gowraganahalli Jagadeesh
Journal:  J Cardiovasc Pharmacol       Date:  2010-11       Impact factor: 3.105

9.  Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume.

Authors:  Carsten Lundby; Jonas Juhl Thomsen; Robert Boushel; Maria Koskolou; Jørgen Warberg; José A L Calbet; Paul Robach
Journal:  J Physiol       Date:  2006-11-09       Impact factor: 5.182

10.  Anemia in patients with type 1 diabetes.

Authors:  Merlin C Thomas; Richard J MacIsaac; Con Tsalamandris; Lynda Molyneaux; Inna Goubina; Greg Fulcher; Dennis Yue; George Jerums
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

View more
  9 in total

1.  Resting heart rate variability and exercise capacity in Type 1 diabetes.

Authors:  Luke C Wilson; Karen C Peebles; Neil A Hoye; Patrick Manning; Catherine Sheat; Michael J A Williams; Gerard T Wilkins; Genevieve A Wilson; James C Baldi
Journal:  Physiol Rep       Date:  2017-04

2.  Hemoglobin concentration, total hemoglobin mass and plasma volume in patients: implications for anemia.

Authors:  James M Otto; James O M Plumb; Eleri Clissold; Shriya B Kumar; Denis J Wakeham; Walter Schmidt; Michael P W Grocott; Toby Richards; Hugh E Montgomery
Journal:  Haematologica       Date:  2017-06-08       Impact factor: 9.941

Review 3.  Consequences of Type 1 and 2 Diabetes Mellitus on the Cardiovascular Regulation During Exercise: A Brief Review.

Authors:  Silvana Roberto; Antonio Crisafulli
Journal:  Curr Diabetes Rev       Date:  2017-10-11

Review 4.  Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning.

Authors:  Antonio Crisafulli; Pasquale Pagliaro; Silvana Roberto; Lucia Cugusi; Giuseppe Mercuro; Antigone Lazou; Christophe Beauloye; Luc Bertrand; Derek J Hausenloy; Manuela Aragno; Claudia Penna
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

5.  Altered Expiratory Flow Dynamics at Peak Exercise in Adult Men With Well-Controlled Type 1 Diabetes.

Authors:  Vesa V Hyrylä; Antti-Pekka E Rissanen; Juha E Peltonen; Anne S Koponen; Heikki O Tikkanen; Mika P Tarvainen
Journal:  Front Physiol       Date:  2022-02-18       Impact factor: 4.566

Review 6.  Body temperature regulation in diabetes.

Authors:  Glen P Kenny; Ronald J Sigal; Ryan McGinn
Journal:  Temperature (Austin)       Date:  2016-01-04

7.  Replicating measurements of total hemoglobin mass (tHb-mass) within a single day: precision of measurement; feasibility and safety of using oxygen to expedite carbon monoxide clearance.

Authors:  James O M Plumb; Shriya Kumar; James Otto; Walter Schmidt; Toby Richards; Hugh E Montgomery; Mike P W Grocott
Journal:  Physiol Rep       Date:  2018-09

8.  Application of the optimized carbon monoxide rebreathing method for the measurement of total haemoglobin mass in chronic liver disease.

Authors:  James O M Plumb; James M Otto; Shriya B Kumar; Mark Wright; Walter Schmidt; Michael P W Grocott; Hugh E Montgomery
Journal:  Physiol Rep       Date:  2020-03

9.  Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome.

Authors:  James M Otto; Hugh E Montgomery; Toby Richards
Journal:  Extrem Physiol Med       Date:  2013-11-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.